Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.795 USD | -0.18% | +10.91% | -12.11% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Hawkins
CEO | Chief Executive Officer | 75 | 10-08-31 |
Lori Lawley
DFI | Director of Finance/CFO | 40 | 20-02-29 |
John McKew
PSD | President | 59 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | 22-04-30 | |
Bradley Powers
CMP | Compliance Officer | 45 | 19-08-02 |
Robert J. Davis
COO | Chief Operating Officer | - | 20-04-30 |
Lisa Miller
IRC | Investor Relations Contact | - | - |
Eddie L. Varnado
AUD | Comptroller/Controller/Auditor | - | 21-04-18 |
Aaron Schuchart
PRN | Corporate Officer/Principal | 59 | 20-05-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lota Zoth
BRD | Director/Board Member | 64 | 12-10-31 |
Richard Hawkins
CEO | Chief Executive Officer | 75 | 10-08-31 |
Kevin Lalande
BRD | Director/Board Member | 51 | 13-12-31 |
Thomas Raffin
BRD | Director/Board Member | 77 | 98-12-31 |
Joseph McCracken
BRD | Director/Board Member | 70 | 20-03-22 |
Director/Board Member | 64 | 21-02-12 | |
Director/Board Member | 45 | 18-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,139,661 | 5,289,307 ( 64.98 %) | 23,173 ( 0.2847 %) | 64.98 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.11% | 22.69M | |
+0.93% | 43.84B | |
+5.97% | 41.68B | |
+45.15% | 41.25B | |
-10.92% | 27.04B | |
+8.02% | 25.53B | |
-25.24% | 18.18B | |
-3.47% | 12.29B | |
+24.72% | 12.29B | |
+6.86% | 11.15B |
- Stock Market
- Equities
- LUMO Stock
- Company Lumos Pharma, Inc.